Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 152 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Eribulin in breast cancer: Current insights and therapeutic perspectives.
Oey O, Wijaya W, Redfern A
World J Exp Med, 14(2):92558, 20 Jun 2024
Cited by: 0 articles | PMID: 38948420
Add to export list Review
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).
Cardoso F, Paluch-Shimon S, Schumacher-Wulf E, Matos L, Gelmon K, Aapro MS, Bajpai J, Barrios CH, Bergh J, Bergsten-Nordström E, Biganzoli L, Cardoso MJ, Carey LA, Chavez-MacGregor M, Chidebe R, Cortés J, Curigliano G, Dent RA, El Saghir NS, [...] Winer EP
Breast, 76:103756, 28 May 2024
Cited by: 8 articles | PMID: 38896983 | PMCID: PMC11231614
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Treatment with nanosomal paclitaxel lipid suspension versus conventional paclitaxel in metastatic breast cancer patients - a multicenter, randomized, comparative, phase II/III clinical study.
Satheesh CT, Taran R, Singh JK, Shrivastav SP, Vithalani NK, Mukherjee KK, Nagarkar RV, Maksud T, Mehta AO, Srinivasan K, Vikranth M, Sonawane SR, Ahmad A, Sheikh S, Ali SM, Patel R, Paithankar M, Patel L, Rajani A, [...] Ahmad I
Ther Adv Med Oncol, 16:17588359241236442, 25 Apr 2024
Cited by: 0 articles | PMID: 38680290 | PMCID: PMC11047258
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls.
Park SJ, Son JH, Kong TW, Chang SJ, Kim HS
Front Oncol, 14:1203129, 09 Feb 2024
Cited by: 1 article | PMID: 38406817 | PMCID: PMC10884224
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer.
Alhaj-Suliman SO, Naguib YW, Wafa EI, Saha S, Ebeid K, Meng X, Mohammed HH, Abuo-Rahma GEA, Yang S, Salem AK
Biomaterials, 296:122093, 17 Mar 2023
Cited by: 3 articles | PMID: 36965280 | PMCID: PMC10092294
Add to export list Free full text in Europe PMC
Alleviation of cisplatin-induced neuropathic pain, neuronal apoptosis, and systemic inflammation in mice by rapamycin.
Alotaibi M, Al-Aqil F, Alqahtani F, Alanazi M, Nadeem A, Ahmad SF, Lapresa R, Alharbi M, Alshammari A, Alotaibi M, Saleh T, Alrowis R
Front Aging Neurosci, 14:891593, 28 Sep 2022
Cited by: 2 articles | PMID: 36248001 | PMCID: PMC9554141
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial.
Kerckhove N, Tougeron D, Lepage C, Pezet D, Le Malicot K, Pelkowski M, Pereira B, Balayssac D
BMC Cancer, 22(1):742, 07 Jul 2022
Cited by: 3 articles | PMID: 35799138 | PMCID: PMC9264497
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
How translational modeling in oncology needs to get the mechanism just right.
Yates JWT, Fairman DA
Clin Transl Sci, 15(3):588-600, 12 Nov 2021
Cited by: 5 articles | PMID: 34716976 | PMCID: PMC8932697
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review.
Sempere-Bigorra M, Julián-Rochina I, Cauli O
Curr Oncol, 28(4):3124-3138, 19 Aug 2021
Cited by: 9 articles | PMID: 34436039 | PMCID: PMC8395481
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Less Toxic Chemotherapy in Locally Advanced Breast Cancer.
Carpenter J, Forero A, Falkson CI, Nabell LM, De Los Santos JF, Krontiras H, Bland KI, Li Y, Bae S
South Med J, 113(11):559-563, 01 Nov 2020
Cited by: 1 article | PMID: 33140109 | PMCID: PMC8787856
Add to export list Free full text in Europe PMC
Is nab-paclitaxel better than conventional taxanes as neoadjuvant therapy for breast cancer? A meta-analysis.
Li Y, Lu X, Lin Q, Li W
J Int Med Res, 48(8):300060520943473, 01 Aug 2020
Cited by: 4 articles | PMID: 32762463 | PMCID: PMC7416144
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Nanomedicine for Acute Brain Injuries: Insight from Decades of Cancer Nanomedicine.
Kandell RM, Waggoner LE, Kwon EJ
Mol Pharm, 18(2):522-538, 25 Jun 2020
Cited by: 9 articles | PMID: 32584042 | PMCID: PMC7759589
Add to export list Review Free full text in Europe PMC
Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis.
Chou PL, Huang YP, Cheng MH, Rau KM, Fang YP
Int J Nanomedicine, 15:1731-1743, 12 Mar 2020
Cited by: 11 articles | PMID: 32210563 | PMCID: PMC7075337
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer.
Abu Samaan TM, Samec M, Liskova A, Kubatka P, Büsselberg D
Biomolecules, 9(12):E789, 27 Nov 2019
Cited by: 184 articles | PMID: 31783552 | PMCID: PMC6995578
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
Kerckhove N, Busserolles J, Stanbury T, Pereira B, Plence V, Bonnetain F, Krakowski I, Eschalier A, Pezet D, Balayssac D
BMJ Open, 9(6):e027770, 09 Jun 2019
Cited by: 9 articles | PMID: 31182448 | PMCID: PMC6561607
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.
Iqbal J, Abbasi BA, Ahmad R, Mahmood T, Ali B, Khalil AT, Kanwal S, Shah SA, Alam MM, Badshah H, Munir A
Appl Microbiol Biotechnol, 102(22):9449-9470, 15 Sep 2018
Cited by: 22 articles | PMID: 30219952
Add to export list Review
The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors.
Matsuoka H, Nakamura K, Matsubara Y, Ida N, Saijo M, Ogawa C, Masuyama H
Int J Gynecol Cancer, 28(7):1394-1402, 01 Sep 2018
Cited by: 2 articles | PMID: 30095701
Add to export list
Strategies to improve tumor penetration of nanomedicines through nanoparticle design.
Zhang YR, Lin R, Li HJ, He WL, Du JZ, Wang J
Wiley Interdiscip Rev Nanomed Nanobiotechnol, 11(1):e1519, 16 Apr 2018
Cited by: 79 articles | PMID: 29659166
Add to export list Review
Impact of Glutathione Modulation on Stability and Pharmacokinetic Profile of Redox-Sensitive Nanogels.
Drude N, Winz OH, Mottaghy FM, Roller M, Königs H, Möller M, Singh S, Morgenroth A
Small, 14(14):e1704093, 19 Feb 2018
Cited by: 8 articles | PMID: 29457349
Add to export list
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study.
Lazzaro C, Barone C, Caprioni F, Cascinu S, Falcone A, Maiello E, Milella M, Pinto C, Reni M, Tortora G
Expert Rev Pharmacoecon Outcomes Res, 18(4):435-446, 20 Apr 2018
Cited by: 8 articles | PMID: 29641931
Add to export list
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.
Zirpoli GR, McCann SE, Sucheston-Campbell LE, Hershman DL, Ciupak G, Davis W, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS, Ambrosone CB
J Natl Cancer Inst, 109(12), 01 Dec 2017
Cited by: 16 articles | PMID: 29546345 | PMCID: PMC6075365
Add to export list Free full text in Europe PMC
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).
Mehrotra S, Sharma MR, Gray E, Wu K, Barry WT, Hudis C, Winer EP, Lyss AP, Toppmeyer DL, Moreno-Aspitia A, Lad TE, Valasco M, Overmoyer B, Rugo H, Ratain MJ, Gobburu JV
AAPS J, 19(5):1411-1423, 15 Jun 2017
Cited by: 3 articles | PMID: 28620884 | PMCID: PMC5711539
Add to export list Free full text in Europe PMC
Paclitaxel: What has been done and the challenges remain ahead.
Bernabeu E, Cagel M, Lagomarsino E, Moretton M, Chiappetta DA
Int J Pharm, 526(1-2):474-495, 10 May 2017
Cited by: 115 articles | PMID: 28501439
Add to export list Review
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.
Starobova H, Vetter I
Front Mol Neurosci, 10:174, 31 May 2017
Cited by: 247 articles | PMID: 28620280 | PMCID: PMC5450696
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021).
Lee SW, Kim YM, Cho CH, Kim YT, Kim SM, Hur SY, Kim JH, Kim BG, Kim SC, Ryu HS, Kang SB
Cancer Res Treat, 50(1):195-203, 21 Mar 2017
Cited by: 32 articles | PMID: 28324920 | PMCID: PMC5784626
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 152 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Eribulin in breast cancer: Current insights and therapeutic perspectives.

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).

Treatment with nanosomal paclitaxel lipid suspension versus conventional paclitaxel in metastatic breast cancer patients - a multicenter, randomized, comparative, phase II/III clinical study.

Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls.

A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer.

Alleviation of cisplatin-induced neuropathic pain, neuronal apoptosis, and systemic inflammation in mice by rapamycin.

Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial.

How translational modeling in oncology needs to get the mechanism just right.

Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review.

Less Toxic Chemotherapy in Locally Advanced Breast Cancer.

Is nab-paclitaxel better than conventional taxanes as neoadjuvant therapy for breast cancer? A meta-analysis.

Nanomedicine for Acute Brain Injuries: Insight from Decades of Cancer Nanomedicine.

Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis.

Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer.

Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.

Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.

The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors.

Strategies to improve tumor penetration of nanomedicines through nanoparticle design.

Impact of Glutathione Modulation on Stability and Pharmacokinetic Profile of Redox-Sensitive Nanogels.

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study.

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.

Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).

Paclitaxel: What has been done and the challenges remain ahead.

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.

An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021).

Partnerships & funding